Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

FDA accepts first sBLA for an immuno-oncology regimen

June 3, 2015

FDA accepts for review sBLA for Keytruda in advanced NSCLC

June 2, 2015

Amgen and Merck & Co. expand immunotherapy collaboration

June 2, 2015

Lilly and AstraZeneca enter clinical trial collaboration to study MEDI-4736 with ramucirumab

June 2, 2015

University of Montpellier and INSERM jointly patent new HER3 antibodies

May 29, 2015

ADC Therapeutics and LivTech sign antibody license agreement

May 28, 2015

Lipo-MERIT: a novel tetravalent RNA cancer vaccine

May 26, 2015

Nivolumab receives EMA recommendation for squamous NSCLC

May 25, 2015

EMA committee hands down positive opinion for Keytruda in advanced melanoma

May 25, 2015

U.S. scientists report anti-EFNA4 antibody-drug conjugates

May 25, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...